[{"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-001", "question": "A 43-year-old woman undergoes bilateral DIEP free flap breast reconstruction after nipple-sparing mastectomy. Intraoperatively, the right flap requires an 11-cm venous graft to reach the internal mammary vein, and flow is satisfactory at closure. On postoperative day 3, she develops progressive swelling and violaceous discoloration of the right flap with brisk bleeding on pinprick and Dopplerable arterial signal in the pedicle but no venous signal. Exploration shows a patent arterial anastomosis, a soft flap, and a congested, thrombotic venous graft with limited nearby recipient veins. The contralateral internal mammary and thoracodorsal systems are already occupied by the left flap. Which salvage strategy offers the highest likelihood of durable flap survival?", "options": ["Shortening the flap pedicle with reanastomosis directly to the internal mammary vein after partial flap debulking to reduce reach and venous load", "Use of a retrograde internal mammary vein anastomosis via a newly dissected contralateral internal mammary perforator and interposition venous graft", "Creation of a venous cross-over (cross-chest) anastomosis from the congested flap vein to a contralateral DIEP flap superficial inferior epigastric vein branch", "Conversion of the free flap to a pedicled bipedicled transverse rectus abdominis myocutaneous (TRAM) flap by re-establishing inferior epigastric inflow and rotating the flap on its native pedicle", "Immediate complete flap removal and delayed reconstruction with a latissimus dorsi flap and implant after chemotherapy and radiation are completed"], "answer": "C", "answer_index": 2, "explanation": "Venous cross-over using a contralateral flap vein (often SIEV) is a recognized, high-yield salvage when ipsilateral recipient veins are exhausted, preserving a viable free flap. Shortening the pedicle (A) is not feasible given the reach problem and does not address lack of recipient vein; retrograde IMV with another vein graft (B) adds another long, failure-prone segment. Converting to pedicled TRAM (D) is not realistic once the flap is fully disconnected. Immediate flap loss (E) is last resort and avoids a proven microvascular salvage option.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Plastic Surgery", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The question presents a clear clinical scenario: venous congestion of a free flap with patent arterial inflow, where ipsilateral recipient veins are exhausted or unusable. The goal is microsurgical salvage. Option C (venous cross-over to the contralateral flap) is a recognized, sophisticated salvage technique ('lifeboat' anastomosis) in bilateral breast reconstruction, utilizing the often-unused superficial system (SIEV) or a branch of the deep system of the healthy contralateral flap. The distractors are effectively ruled out by the stem constraints or anatomical impossibility: Option A is contradicted by the stated need for a long graft (11 cm) to reach the vessels; Option D is anatomically impossible as a DIEP flap is disconnected from the rectus muscle and superior epigastric system required for a pedicled TRAM, and the inferior pedicle is already severed; Option E is a failure of salvage, not a salvage strategy. The item is medically accurate and logically sound, testing a specific advanced management principle.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The question presents a clear clinical scenario: venous congestion of a free flap with patent arterial inflow, where ipsilateral recipient veins are exhausted or unusable. The goal is microsurgical salvage. Option C (venous cross-over to the contralateral flap) is a recognized, sophisticated salvage technique ('lifeboat' anastomosis) in bilateral breast reconstruction, utilizing the often-unused superficial system (SIEV) or a branch of the deep system of the healthy contralateral flap. The distractors are effectively ruled out by the stem constraints or anatomical impossibility: Option A is contradicted by the stated need for a long graft (11 cm) to reach the vessels; Option D is anatomically impossible as a DIEP flap is disconnected from the rectus muscle and superior epigastric system required for a pedicled TRAM, and the inferior pedicle is already severed; Option E is a failure of salvage, not a salvage strategy. The item is medically accurate and logically sound, testing a specific advanced management principle.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-002", "question": "A 56-year-old man presents with progressive gait ataxia, urinary urgency, and cognitive slowing over 10 months. MRI shows ventriculomegaly out of proportion to mild cortical atrophy, but in addition there is a subtle nodular T1-hypointense, T2-hyperintense lesion in the posterior third ventricle near the aqueduct, with minimal enhancement and no diffusion restriction. Cine phase-contrast MRI demonstrates preserved CSF stroke volume at the cerebral aqueduct. A high-volume lumbar tap test produces only transient, equivocal improvement. Which is the most appropriate next neurosurgical management?", "options": ["Programmable ventriculoperitoneal shunt placement without further workup, given classic normal-pressure hydrocephalus symptoms", "Endoscopic third ventriculostomy with concurrent biopsy of the third ventricular lesion", "Endoscopic biopsy and possible debulking of the third ventricular lesion without CSF diversion, followed by observation", "Stereotactic radiosurgery targeted to the third ventricular lesion followed by reassessment of hydrocephalus", "External lumbar drainage trial over 72 hours before deciding on shunt placement"], "answer": "B", "answer_index": 1, "explanation": "The combination of ventriculomegaly and a small obstructive-appearing lesion near the aqueduct suggests a secondary obstructive hydrocephalus rather than idiopathic NPH; ETV addresses obstruction and allows tissue diagnosis for a possible low-grade tumor or colloid-like lesion. Shunting alone (A, E) ignores a likely focal obstructive cause and risks shunt dependence. Biopsy alone (C) does not treat hydrocephalus. SRS (D) is premature without histology and does not immediately relieve CSF obstruction.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The item is logically invalid due to a critical contradiction between the clinical data provided and the pathophysiology required to support the keyed answer. The stem describes a patient with ventriculomegaly and a third ventricular lesion but explicitly states that Cine phase-contrast MRI demonstrates \\\"preserved CSF stroke volume at the cerebral aqueduct.\\\" In neuroradiology, preserved flow/stroke volume at the aqueduct confirms patency and rules out aqueductal stenosis (obstructive hydrocephalus). However, the keyed answer (ETV) and its rationale rely entirely on the premise that the patient has \\\"secondary obstructive hydrocephalus.\\\" If the aqueduct is patent, the hydrocephalus is communicating; for communicating hydrocephalus with an equivocal tap test, the standard of care is an External Lumbar Drainage trial (Option E) or shunting, not ETV. Furthermore, if the lesion is not obstructing flow (as proven by the Cine MRI), it may be an incidental non-surgical lesion (e.g., tectal glioma), making immediate biopsy (Option B) unnecessarily aggressive compared to workup for NPH. The stem forces a choice between treating a condition explicitly ruled out by the diagnostic findings or ignoring a potential mass.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"C\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item is logically invalid due to a critical contradiction between the clinical data provided and the pathophysiology required to support the keyed answer. The stem describes a patient with ventriculomegaly and a third ventricular lesion but explicitly states that Cine phase-contrast MRI demonstrates \"preserved CSF stroke volume at the cerebral aqueduct.\" In neuroradiology, preserved flow/stroke volume at the aqueduct confirms patency and rules out aqueductal stenosis (obstructive hydrocephalus). However, the keyed answer (ETV) and its rationale rely entirely on the premise that the patient has \"secondary obstructive hydrocephalus.\" If the aqueduct is patent, the hydrocephalus is communicating; for communicating hydrocephalus with an equivocal tap test, the standard of care is an External Lumbar Drainage trial (Option E) or shunting, not ETV. Furthermore, if the lesion is not obstructing flow (as proven by the Cine MRI), it may be an incidental non-surgical lesion (e.g., tectal glioma), making immediate biopsy (Option B) unnecessarily aggressive compared to workup for NPH. The stem forces a choice between treating a condition explicitly ruled out by the diagnostic findings or ignoring a potential mass.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "C", "verdict": "FAIL", "fail_reason": "C"}, "judge_verdict": "FAIL", "judge_fail_reason": "C", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-003", "question": "A 68-year-old man with cT3N1M0 distal esophageal adenocarcinoma receives neoadjuvant chemoradiation with carboplatin/paclitaxel and 50.4 Gy in 28 fractions using IMRT. He has severe baseline interstitial lung disease (UIP pattern) with DLCO 35% predicted. At multidisciplinary review before simulation, the radiation oncologist must choose a planning goal that most reduces the risk of fatal radiation pneumonitis while still allowing adequate target coverage. Which constraint is most critical to prioritize in this scenario?", "options": ["Mean lung dose (MLD) <10 Gy, even if heart V40 increases modestly", "Total lung V20 <20%, accepting an MLD up to 15 Gy", "Ipsilateral lung V30 <15% with no specific constraint on contralateral lung", "Total lung V5 <40% while relaxing V20 and MLD constraints", "Heart V30 <30% with no further reduction in lung dose beyond standard constraints"], "answer": "A", "answer_index": 0, "explanation": "In patients with severe underlying ILD, data show the mean lung dose is the best single predictor of lethal pneumonitis; keeping MLD as low as possible (often <10 Gy) is paramount, even if cardiac doses increase somewhat. V20 (B) is important but less predictive in ILD compared with MLD. Ipsilateral V30 constraints (C) and V5 (D) are less strongly tied to high-grade pneumonitis. Prioritizing heart sparing (E) over lung constraints is inappropriate in a patient at extreme pulmonary risk.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The vignette describes a patient with esophageal cancer and severe interstitial lung disease (UIP pattern), placing him at extremely high risk for fatal radiation pneumonitis. In this specific high-risk population, minimizing lung dose is the absolute priority, often superseding standard cardiac constraints because ILD exacerbation is acute and frequently lethal, whereas cardiac toxicity is a late effect. Option A (MLD < 10 Gy) represents the strictest and most appropriate lung constraint among the choices, correctly identifying that keeping the mean lung dose exceptionally low is critical for safety in ILD patients. Option B allows an MLD up to 15 Gy, which is significantly riskier than 10 Gy in this context. Option D suggests relaxing V20/MLD to improve V5, a trade-off that increases the risk of high-dose injury. Option E prioritizes heart sparing over lung, which is clinically inappropriate given the patient's immediate pulmonary mortality risk. The item is medically accurate and logically sound, requiring the examinee to apply risk-stratified planning priorities.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The vignette describes a patient with esophageal cancer and severe interstitial lung disease (UIP pattern), placing him at extremely high risk for fatal radiation pneumonitis. In this specific high-risk population, minimizing lung dose is the absolute priority, often superseding standard cardiac constraints because ILD exacerbation is acute and frequently lethal, whereas cardiac toxicity is a late effect. Option A (MLD < 10 Gy) represents the strictest and most appropriate lung constraint among the choices, correctly identifying that keeping the mean lung dose exceptionally low is critical for safety in ILD patients. Option B allows an MLD up to 15 Gy, which is significantly riskier than 10 Gy in this context. Option D suggests relaxing V20/MLD to improve V5, a trade-off that increases the risk of high-dose injury. Option E prioritizes heart sparing over lung, which is clinically inappropriate given the patient's immediate pulmonary mortality risk. The item is medically accurate and logically sound, requiring the examinee to apply risk-stratified planning priorities.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-004", "question": "A 63-year-old woman undergoes right upper lobectomy via VATS for a 2.8-cm peripheral squamous cell carcinoma. On postoperative day 5 she develops acute dyspnea and subcutaneous emphysema. Chest CT shows a large posterior membranous tracheal defect 2 cm above the carina communicating with a loculated right pleural air collection. Bronchoscopy confirms a 1.5-cm full-thickness laceration with necrotic edges in a fragile, steroid-exposed airway. The right main bronchus is intact; there is no mediastinitis and she is hemodynamically stable but ventilator dependent. Which operative strategy provides the best chance of durable repair and respiratory recovery?", "options": ["Primary end-to-end tracheal resection with anastomosis and neck flexion, without tissue interposition", "Right posterolateral thoracotomy with direct tracheal defect closure reinforced by a pedicled intercostal muscle flap", "Cervical approach with placement of a covered tracheal stent and no open repair", "Right thoracotomy with tracheal defect closure buttressed by a pedicled latissimus dorsi flap and distal tracheostomy below the repair", "Clamshell thoracotomy with carinal resection and reconstruction to isolate the injured segment"], "answer": "B", "answer_index": 1, "explanation": "A posterior distal tracheal laceration communicating with the ipsilateral pleura after lobectomy is best approached via thoracotomy with direct repair and vascularized intercostal muscle buttress, preserving remaining lung and avoiding extensive resection. Circumferential resection (A, E) is excessive and risky in a fragile airway. Covered stenting alone (C) in a full-thickness laceration with necrotic edges risks dehiscence and mediastinitis. Latissimus flap plus distal tracheostomy (D) is more morbid and generally unnecessary compared with intercostal muscle reinforcement.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Thoracic Surgery", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a severe iatrogenic complication: a large (1.5 cm), necrotic, full-thickness distal tracheal laceration communicating with the pleura in a ventilator-dependent patient. Conservative management or stenting (Option C) is inappropriate due to the necrotic edges and pleural communication (risk of persistent fistula/mediastinitis). Surgical repair is indicated. Option B represents the standard of care: right thoracotomy provides optimal access to the distal trachea/carina, and direct suture repair reinforced with a vascularized intercostal muscle flap is the preferred technique to ensure healing in a fragile, steroid-exposed airway. Option A (resection) is unnecessary for a longitudinal tear and carries high anastomotic risk. Option D is anatomically unsound because a 'distal tracheostomy' below a lesion 2 cm above the carina is not feasible (it would be intrathoracic/carinal). Option E is excessively morbid. The item is medically accurate and logically sound.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a severe iatrogenic complication: a large (1.5 cm), necrotic, full-thickness distal tracheal laceration communicating with the pleura in a ventilator-dependent patient. Conservative management or stenting (Option C) is inappropriate due to the necrotic edges and pleural communication (risk of persistent fistula/mediastinitis). Surgical repair is indicated. Option B represents the standard of care: right thoracotomy provides optimal access to the distal trachea/carina, and direct suture repair reinforced with a vascularized intercostal muscle flap is the preferred technique to ensure healing in a fragile, steroid-exposed airway. Option A (resection) is unnecessary for a longitudinal tear and carries high anastomotic risk. Option D is anatomically unsound because a 'distal tracheostomy' below a lesion 2 cm above the carina is not feasible (it would be intrathoracic/carinal). Option E is excessively morbid. The item is medically accurate and logically sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-005", "question": "A 72-year-old man with prior left common femoral endarterectomy and iliac stenting presents with limb-threatening ischemia of the left leg (Rutherford class 5). Angiography shows occluded left external iliac stent and a heavily calcified common femoral artery with poor clamp sites. The profunda femoris is patent with robust collaterals; the superficial femoral artery (SFA) is chronically occluded. Aortobifemoral bypass is contraindicated due to prior hostile laparotomy and significant cardiopulmonary comorbidity. Which revascularization strategy most reliably restores durable inflow to the profunda with acceptable operative risk?", "options": ["Endovascular recanalization and relining of the external iliac stent only, without addressing the common femoral artery", "Retroperitoneal ilio-profunda bypass from the ipsilateral common iliac artery to the profunda femoris artery", "Axillo-bifemoral bypass using an 8-mm ringed PTFE graft with proximal hood anastomosis to the axillary artery", "Femoral-femoral crossover bypass from the contralateral common femoral artery to the ipsilateral profunda femoris artery", "Hybrid repair with endovascular iliac stent relining plus open common femoral endarterectomy and patch angioplasty to the profunda origin"], "answer": "E", "answer_index": 4, "explanation": "A hybrid approach-iliac stent relining to restore inflow plus open common femoral endarterectomy/patch to the profunda-directly corrects both inflow and the key outflow vessel while avoiding aortic surgery. Isolated iliac relining (A) leaves the diseased CFA uncorrected. Ilio-profunda bypass (B) is more invasive than necessary in a hostile abdomen. Axillo-bifemoral (C) and fem-fem crossover (D) ignore the ipsilateral inflow lesion and are less durable or anatomically suboptimal in this context.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Vascular Surgery", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical scenario describes a patient with multilevel arterial occlusive disease (iliac inflow occlusion and common femoral artery disease) presenting with critical limb ischemia. The goal is to restore inflow to the patent profunda femoris artery. Option A is inadequate because it addresses only the inflow (iliac) while ignoring the significant outflow obstruction at the common femoral artery (CFA), likely leading to early failure. Options C (axillo-bifemoral) and D (femoral-femoral) are extra-anatomic bypasses; these generally have inferior long-term patency compared to inline reconstruction and are reserved for cases where inline flow cannot be established. Additionally, Option D would require exposing the contralateral groin and the ipsilateral hostile groin. Option B (ilio-profunda bypass) is a durable option but requires a retroperitoneal approach, which carries higher operative risk than an endovascular intervention, particularly in a patient with cardiopulmonary comorbidities. Option E (Hybrid repair) represents the modern standard of care for combined iliac and CFA disease (TASC C/D lesions). It restores durable inline flow, allows for endovascular proximal control (mitigating the 'poor clamp site' issue), and is less invasive than a fully open retroperitoneal bypass. Despite the technical challenge of a 'redo' groin, the hybrid approach is the most appropriate 'best answer' among the choices provided.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical scenario describes a patient with multilevel arterial occlusive disease (iliac inflow occlusion and common femoral artery disease) presenting with critical limb ischemia. The goal is to restore inflow to the patent profunda femoris artery. Option A is inadequate because it addresses only the inflow (iliac) while ignoring the significant outflow obstruction at the common femoral artery (CFA), likely leading to early failure. Options C (axillo-bifemoral) and D (femoral-femoral) are extra-anatomic bypasses; these generally have inferior long-term patency compared to inline reconstruction and are reserved for cases where inline flow cannot be established. Additionally, Option D would require exposing the contralateral groin and the ipsilateral hostile groin. Option B (ilio-profunda bypass) is a durable option but requires a retroperitoneal approach, which carries higher operative risk than an endovascular intervention, particularly in a patient with cardiopulmonary comorbidities. Option E (Hybrid repair) represents the modern standard of care for combined iliac and CFA disease (TASC C/D lesions). It restores durable inline flow, allows for endovascular proximal control (mitigating the 'poor clamp site' issue), and is less invasive than a fully open retroperitoneal bypass. Despite the technical challenge of a 'redo' groin, the hybrid approach is the most appropriate 'best answer' among the choices provided.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-006", "question": "A 45-year-old woman with a 1.7-cm left adrenal incidentaloma has mild hypertension and intermittent headaches. She is on a thiazide diuretic. Labs show: K 3.3 mmol/L, plasma aldosterone 15 ng/dL, plasma renin activity 0.1 ng/mL/h (suppressed), and aldosterone-renin ratio (ARR) of 150 (elevated). Confirmatory saline suppression test is borderline. Adrenal vein sampling (AVS) without cosyntropin stimulation reveals: cortisol-corrected aldosterone lateralization index (LI) of 2.2, but contralateral suppression index <0.3. Which is the most appropriate next step in management?", "options": ["Left laparoscopic adrenalectomy, given imaging-concordant unilateral lesion and contralateral suppression", "Continue medical therapy with mineralocorticoid receptor antagonists because lateralization index is below traditional cutoff", "Repeat AVS with cosyntropin stimulation to clarify lateralization before deciding on surgery", "Proceed to partial (cortical-sparing) resection of the left adrenal nodule to preserve adrenal function", "Observation without intervention, as results suggest nonfunctioning incidentaloma"], "answer": "A", "answer_index": 0, "explanation": "Current AVS interpretation emphasizes both lateralization and contralateral suppression; a low contralateral aldosterone/cortisol ratio (<0.3) strongly indicates unilateral disease even with modest LI, especially with concordant imaging and biochemical primary aldosteronism. Medical therapy (B) or observation (E) ignores resectable unilateral disease. Repeating AVS (C) is unnecessary given clear suppression. Partial adrenalectomy (D) is not standard for unilateral aldosterone-producing adenomas and risks recurrence.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Endocrine", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The patient has confirmed Primary Aldosteronism (PA) with a left adrenal nodule. The critical teaching point involves interpreting Adrenal Vein Sampling (AVS) results that fall in the 'gray zone.' While a Lateralization Index (LI) of 2.2 is often considered indeterminate (standard cutoffs for unilateral disease are typically >4 or >3), the Contralateral Suppression Index (CSI) of <0.3 indicates strong suppression of the contralateral gland. In the presence of a concordant anatomical lesion (left nodule) and contralateral suppression, the likelihood of unilateral aldosterone hypersecretion is very high, and adrenalectomy is the standard of care for potential cure. Option A correctly synthesizes the imaging concordance and suppression data to recommend surgery. Option B relies rigidly on the LI cutoff, ignoring the suppression data and denying a young patient a potential cure. Option C is unnecessary given the actionable data already obtained. Option D (partial resection) is not the standard of care for unilateral PA due to recurrence risks. The item is logically valid and medically accurate, testing high-level clinical judgment.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The patient has confirmed Primary Aldosteronism (PA) with a left adrenal nodule. The critical teaching point involves interpreting Adrenal Vein Sampling (AVS) results that fall in the 'gray zone.' While a Lateralization Index (LI) of 2.2 is often considered indeterminate (standard cutoffs for unilateral disease are typically >4 or >3), the Contralateral Suppression Index (CSI) of <0.3 indicates strong suppression of the contralateral gland. In the presence of a concordant anatomical lesion (left nodule) and contralateral suppression, the likelihood of unilateral aldosterone hypersecretion is very high, and adrenalectomy is the standard of care for potential cure. Option A correctly synthesizes the imaging concordance and suppression data to recommend surgery. Option B relies rigidly on the LI cutoff, ignoring the suppression data and denying a young patient a potential cure. Option C is unnecessary given the actionable data already obtained. Option D (partial resection) is not the standard of care for unilateral PA due to recurrence risks. The item is logically valid and medically accurate, testing high-level clinical judgment.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-007", "question": "A 63-year-old man with compensated cirrhosis (Child-Pugh A, MELD 9) has a 2.3-cm hepatocellular carcinoma (HCC) in segment VII adjacent to the right hepatic vein and diaphragm. He has portal hypertension with platelets 70,000/µL, small varices, and HVPG 13 mmHg. Liver function is preserved; he is not yet listed for transplant due to social issues. Which management offers the best balance of long-term oncologic control and hepatic reserve preservation?", "options": ["Open right posterior sectionectomy including segment VII and part of VIII", "Laparoscopic wedge resection of segment VII tumor with Pringle maneuver", "Ultrasound-guided percutaneous radiofrequency ablation (RFA) of the lesion", "Transarterial chemoembolization (TACE) followed by reassessment for ablation or resection", "Listing for liver transplantation without locoregional therapy until a donor becomes available"], "answer": "C", "answer_index": 2, "explanation": "For a solitary ≤3-cm HCC in a cirrhotic liver with significant portal hypertension and thrombocytopenia, percutaneous ablation achieves local control comparable to resection with lower risk of hepatic decompensation. Major or even limited resection (A, B) carries high risk in portal hypertension (HVPG >10 mmHg). TACE (D) is inferior to curative-intent ablation for small lesions. Delayed transplant without bridging (E) risks progression beyond criteria and prevents near-term curative local control.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The question presents a classic decision-making scenario for early-stage HCC (BCLC Stage A). The key discriminating factor is the presence of clinically significant portal hypertension (CSPH), indicated by HVPG 13 mmHg, esophageal varices, and platelets 70,000/µL. \\n\\n1. **Resection (A, B):** Despite preserved liver function (Child-Pugh A), CSPH is a major contraindication for liver resection due to the high risk of irreversible postoperative decompensation and mortality. Thus, A and B are incorrect.\\n2. **Transplant (E):** While potentially curative, the patient is explicitly not a candidate due to social issues.\\n3. **TACE (D):** TACE is non-curative and inferior to ablation for solitary lesions <3 cm.\\n4. **RFA (C):** Percutaneous ablation is the standard of care for solitary HCC <3 cm in patients with CSPH. \\n\\n*Note on Anatomy:* The stem notes the lesion is \\\"adjacent to the right hepatic vein,\\\" which historically risks the \\\"heat sink\\\" effect with RFA. While modern practice might prefer Microwave Ablation (MWA) for this location, or laparoscopic approaches to protect the diaphragm, RFA remains the only defensible curative-intent option provided that respects the physiological contraindication to resection. The item is logically valid as C is the unique best answer by elimination of unsafe or non-curative alternatives.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The question presents a classic decision-making scenario for early-stage HCC (BCLC Stage A). The key discriminating factor is the presence of clinically significant portal hypertension (CSPH), indicated by HVPG 13 mmHg, esophageal varices, and platelets 70,000/µL. \n\n1. **Resection (A, B):** Despite preserved liver function (Child-Pugh A), CSPH is a major contraindication for liver resection due to the high risk of irreversible postoperative decompensation and mortality. Thus, A and B are incorrect.\n2. **Transplant (E):** While potentially curative, the patient is explicitly not a candidate due to social issues.\n3. **TACE (D):** TACE is non-curative and inferior to ablation for solitary lesions <3 cm.\n4. **RFA (C):** Percutaneous ablation is the standard of care for solitary HCC <3 cm in patients with CSPH. \n\n*Note on Anatomy:* The stem notes the lesion is \"adjacent to the right hepatic vein,\" which historically risks the \"heat sink\" effect with RFA. While modern practice might prefer Microwave Ablation (MWA) for this location, or laparoscopic approaches to protect the diaphragm, RFA remains the only defensible curative-intent option provided that respects the physiological contraindication to resection. The item is logically valid as C is the unique best answer by elimination of unsafe or non-curative alternatives.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-008", "question": "A 39-year-old man presents with recurrent pancreatitis and is found to have a 2.5-cm enhancing mass in the pancreatic head that encases the intrapancreatic common bile duct, with upstream dilatation but no vascular involvement. EUS-FNA is nondiagnostic twice. CA 19-9 is normal. IgG4 level is mildly elevated at 180 mg/dL (ULN 135). CT shows a capsule-like rim around the lesion and diffuse, sausage-shaped enlargement of the gland. Which management approach is most appropriate?", "options": ["Trial of high-dose corticosteroids with close radiologic follow-up before considering surgery", "Pancreaticoduodenectomy because focal autoimmune pancreatitis cannot be reliably distinguished from adenocarcinoma", "Repeat EUS-FNA with core needle and flow cytometry to exclude lymphoma", "Observation alone with serial imaging in 6 months given low CA 19-9 and mild symptoms", "ERCP with biliary brushing cytology and stent placement, with surgery only if cytology is positive"], "answer": "A", "answer_index": 0, "explanation": "Imaging findings (capsule-like rim, sausage-shaped gland) and elevated IgG4 strongly suggest type 1 autoimmune pancreatitis; a steroid trial with close monitoring is accepted to avoid unnecessary Whipple when malignancy is not strongly supported. Immediate pancreaticoduodenectomy (B) is premature. Repeat biopsy (C) is less helpful given characteristic features. Observation alone (D) ignores ongoing pancreatitis and biliary obstruction. ERCP cytology (E) has low sensitivity and does not treat underlying inflammatory disease.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a classic presentation of Type 1 Autoimmune Pancreatitis (AIP). Key discriminating features include the \\\"sausage-shaped\\\" enlargement of the pancreas, the \\\"capsule-like rim\\\" (halo sign), and elevated IgG4 levels. While a focal mass in the head of the pancreas raises concern for malignancy, the specific radiologic buzzwords and the negative workup for cancer (normal CA 19-9, two nondiagnostic EUS-FNAs) strongly favor AIP. According to the International Consensus Diagnostic Criteria (ICDC) for AIP, a steroid trial (Option A) is the appropriate management step for patients with typical imaging and collateral evidence (IgG4) to confirm the diagnosis and resolve the obstruction, thereby avoiding high-morbidity surgery like a Whipple procedure (Option B). Option B is incorrect because the findings are characteristic of a benign, treatable etiology. Option C is low-yield after two negative attempts. Option D is unsafe given the obstruction. The question is medically accurate and logically sound.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a classic presentation of Type 1 Autoimmune Pancreatitis (AIP). Key discriminating features include the \"sausage-shaped\" enlargement of the pancreas, the \"capsule-like rim\" (halo sign), and elevated IgG4 levels. While a focal mass in the head of the pancreas raises concern for malignancy, the specific radiologic buzzwords and the negative workup for cancer (normal CA 19-9, two nondiagnostic EUS-FNAs) strongly favor AIP. According to the International Consensus Diagnostic Criteria (ICDC) for AIP, a steroid trial (Option A) is the appropriate management step for patients with typical imaging and collateral evidence (IgG4) to confirm the diagnosis and resolve the obstruction, thereby avoiding high-morbidity surgery like a Whipple procedure (Option B). Option B is incorrect because the findings are characteristic of a benign, treatable etiology. Option C is low-yield after two negative attempts. Option D is unsafe given the obstruction. The question is medically accurate and logically sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-009", "question": "A 26-year-old man presents with splenomegaly, hemoglobin 9.8 g/dL, platelets 130,000/µL, and leukocytes 5,200/µL. Peripheral smear shows tear-drop cells and leukoerythroblastosis. Bone marrow biopsy is markedly fibrotic with 1-2% blasts; JAK2, CALR, and MPL mutations are negative; next-generation sequencing reveals an isolated ASXL1 mutation. Cytogenetics are normal. He is transfusion independent but symptomatic from splenomegaly. DIPSS-plus score indicates intermediate-2 risk primary myelofibrosis. His 10/10 HLA-matched sibling donor is available. Which is the most appropriate management strategy?", "options": ["Begin ruxolitinib and defer allogeneic stem cell transplantation until he becomes transfusion dependent", "Proceed to allogeneic stem cell transplantation in first chronic phase despite triple-negative driver status", "Observation with serial monitoring; ASXL1 mutation alone does not justify early transplant", "Splenectomy followed by hydroxyurea cytoreduction to delay transplantation", "Ruxolitinib bridge therapy for 3-6 months to reduce spleen size, then proceed to planned allogeneic transplantation"], "answer": "E", "answer_index": 4, "explanation": "Intermediate-2 risk myelofibrosis in a young patient with an available donor warrants allogeneic transplant; bridging with ruxolitinib can reduce spleen size and improve conditioning tolerance without compromising transplant timing. Deferring transplant (A, C) risks disease progression. Splenectomy (D) before transplant is reserved for select cases due to morbidity. Immediate transplant without JAK inhibitor optimization (B) may lead to worse peri-transplant outcomes in massively enlarged spleens.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Hematology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette describes a 26-year-old with Intermediate-2 risk Primary Myelofibrosis, high-risk molecular features (triple-negative, ASXL1+), and symptomatic splenomegaly. Allogeneic HCT is the only curative option and is indicated for Intermediate-2/High-risk disease in a fit candidate with a donor, making observation (C) or deferral until progression (A) incorrect. While HCT is the ultimate goal (B), the best answer must address the patient's current symptomatic splenomegaly and optimization for transplant. Current consensus supports using ruxolitinib as bridging therapy (E) to reduce spleen size and inflammatory cytokines prior to conditioning; this improves engraftment and survival rates compared to proceeding immediately with massive splenomegaly. Splenectomy (D) carries significant morbidity and is generally reserved for cases refractory to medical therapy. The item correctly discriminates between the general strategy (transplant) and the specific, optimized management plan (bridging + transplant).\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette describes a 26-year-old with Intermediate-2 risk Primary Myelofibrosis, high-risk molecular features (triple-negative, ASXL1+), and symptomatic splenomegaly. Allogeneic HCT is the only curative option and is indicated for Intermediate-2/High-risk disease in a fit candidate with a donor, making observation (C) or deferral until progression (A) incorrect. While HCT is the ultimate goal (B), the best answer must address the patient's current symptomatic splenomegaly and optimization for transplant. Current consensus supports using ruxolitinib as bridging therapy (E) to reduce spleen size and inflammatory cytokines prior to conditioning; this improves engraftment and survival rates compared to proceeding immediately with massive splenomegaly. Splenectomy (D) carries significant morbidity and is generally reserved for cases refractory to medical therapy. The item correctly discriminates between the general strategy (transplant) and the specific, optimized management plan (bridging + transplant).", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-010", "question": "A 31-year-old woman with systemic lupus erythematosus, class IV lupus nephritis, and high-titer anti-dsDNA presents with a 4-week history of progressive symmetric lower extremity weakness, areflexia, and sensory loss. NCS/EMG show a demyelinating polyneuropathy consistent with CIDP. She is on prednisone 10 mg daily and hydroxychloroquine. Creatinine is 1.3 mg/dL; she has nephrotic-range proteinuria. Which immunologic treatment strategy best balances disease control and long-term toxicity?", "options": ["High-dose IV methylprednisolone pulses followed by oral prednisone 1 mg/kg for both CIDP and lupus nephritis", "IVIG monthly for CIDP plus increase prednisone to 0.5 mg/kg, with no other agents", "Rituximab-based regimen targeting both CIDP and lupus nephritis with tapering of steroids", "Cyclophosphamide induction followed by azathioprine maintenance for lupus and CIDP", "Plasma exchange for CIDP plus mycophenolate mofetil for lupus nephritis"], "answer": "C", "answer_index": 2, "explanation": "Rituximab has efficacy in both CIDP (especially autoimmune-mediated forms) and proliferative lupus nephritis, allowing steroid sparing and addressing shared B-cell pathogenesis. High-dose steroids alone (A, B) worsen long-term toxicity and may be insufficient for nephritis. Cyclophosphamide (D) carries more gonadal and malignancy risk in a young woman. Plasmapheresis (E) gives transient CIDP benefit but does not control chronic B-cell-driven lupus nephritis as effectively as rituximab-based regimens.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Immunology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette describes a young woman with severe SLE (Class IV nephritis) and concurrent CIDP. The question asks for a strategy balancing disease control and toxicity. Standard of care for Class IV LN induction is Mycophenolate Mofetil (MMF) or Cyclophosphamide (CYC). Standard for CIDP includes IVIG, steroids, or PLEX. Option A (steroids alone) is insufficient for LN renal preservation and carries high long-term toxicity. Option B (IVIG) treats CIDP but neglects adequate LN induction (prednisone 0.5 mg/kg alone is typically inadequate for active Class IV). Option D (CYC) is effective for both conditions but carries high infertility risk, making it suboptimal for a 31-year-old woman when alternatives exist. Option E (PLEX + MMF) relies on PLEX, which is an acute/bridging therapy, not a sustainable maintenance strategy. Option C (Rituximab) targets the shared B-cell pathogenesis, is effective for LN (often used in refractory or overlap cases) and CIDP, and avoids CYC's gonadal toxicity. Despite Rituximab typically being second-line for isolated LN, the specific overlap syndrome and toxicity constraints make it the unique best answer among the provided choices.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette describes a young woman with severe SLE (Class IV nephritis) and concurrent CIDP. The question asks for a strategy balancing disease control and toxicity. Standard of care for Class IV LN induction is Mycophenolate Mofetil (MMF) or Cyclophosphamide (CYC). Standard for CIDP includes IVIG, steroids, or PLEX. Option A (steroids alone) is insufficient for LN renal preservation and carries high long-term toxicity. Option B (IVIG) treats CIDP but neglects adequate LN induction (prednisone 0.5 mg/kg alone is typically inadequate for active Class IV). Option D (CYC) is effective for both conditions but carries high infertility risk, making it suboptimal for a 31-year-old woman when alternatives exist. Option E (PLEX + MMF) relies on PLEX, which is an acute/bridging therapy, not a sustainable maintenance strategy. Option C (Rituximab) targets the shared B-cell pathogenesis, is effective for LN (often used in refractory or overlap cases) and CIDP, and avoids CYC's gonadal toxicity. Despite Rituximab typically being second-line for isolated LN, the specific overlap syndrome and toxicity constraints make it the unique best answer among the provided choices.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-011", "question": "A 27-year-old woman sustains a severe crush-avulsion injury to her dominant right forearm in an industrial press. There is segmental loss of the ulnar artery, ulnar nerve (6 cm gap at the wrist), and extensive soft-tissue loss over the volar-ulnar forearm with exposed flexor tendons; radial artery and median nerve are intact. Hand perfusion is marginal via the radial artery. Debridement leaves a 12 × 8 cm wound and nonrepairable FDS/FDP to ring and small fingers. Considering function and reconstructive ladder, what is the optimal reconstructive strategy in a single stage?", "options": ["Local rotational fasciocutaneous flap with reversed interpositional saphenous vein graft for ulnar artery and autologous sural nerve cable grafts for ulnar nerve", "Free anterolateral thigh (ALT) flap with flow-through reconstruction of the ulnar artery and nerve coaptation via sural nerve graft", "Split-thickness skin graft over the exposed tendons after tendon shortening and radial artery-only perfusion", "Pedicled groin flap for soft-tissue coverage and delayed ulnar nerve grafting once the wound bed is stable", "Free radial forearm flap from the contralateral limb including cephalic vein for venous outflow and ulnar nerve primary end-to-end repair under tension"], "answer": "B", "answer_index": 1, "explanation": "A free ALT flap can provide robust soft-tissue coverage and can be configured as a flow-through flap to reconstitute the ulnar artery while allowing concurrent ulnar nerve cable grafting, optimizing perfusion and nerve regeneration in one stage. Local rotational flaps (A) are insufficient for the large defect and lack flow-through capabilities. Skin graft alone (C) is inadequate over exposed tendons and does not restore artery/nerve. Staged groin flap (D) delays nerve repair. A contralateral radial forearm flap (E) sacrifices a major artery and cannot provide tension-free primary nerve repair.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Plastic Surgery", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The item presents a complex composite forearm defect requiring soft tissue coverage, vascular reconstruction (due to 'marginal' perfusion), and nerve reconstruction (6 cm gap). Option B is the correct best answer: the Anterolateral Thigh (ALT) flap is a standard workhorse for large defects (12×8 cm) and can be configured as a flow-through flap to reconstruct the ulnar artery, restoring robust perfusion, while allowing concurrent nerve grafting in a single stage. Option A is incorrect because a 12×8 cm defect is generally too large for local rotational flaps in the forearm, especially within a crush injury zone where local tissue viability is suspect. Option C is inappropriate because skin grafts adhere poorly to exposed tendons without paratenon and do not address the vascular or nerve deficits. Option D describes a multi-stage procedure (pedicled groin flap), contradicting the 'single stage' constraint. Option E is medically incorrect because a 6 cm nerve gap cannot be repaired primarily end-to-end without excessive tension, which leads to failure; a graft is required. The question is logically valid and medically accurate.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item presents a complex composite forearm defect requiring soft tissue coverage, vascular reconstruction (due to 'marginal' perfusion), and nerve reconstruction (6 cm gap). Option B is the correct best answer: the Anterolateral Thigh (ALT) flap is a standard workhorse for large defects (12×8 cm) and can be configured as a flow-through flap to reconstruct the ulnar artery, restoring robust perfusion, while allowing concurrent nerve grafting in a single stage. Option A is incorrect because a 12×8 cm defect is generally too large for local rotational flaps in the forearm, especially within a crush injury zone where local tissue viability is suspect. Option C is inappropriate because skin grafts adhere poorly to exposed tendons without paratenon and do not address the vascular or nerve deficits. Option D describes a multi-stage procedure (pedicled groin flap), contradicting the 'single stage' constraint. Option E is medically incorrect because a 6 cm nerve gap cannot be repaired primarily end-to-end without excessive tension, which leads to failure; a graft is required. The question is logically valid and medically accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-012", "question": "A 54-year-old man with a 2.2-cm pituitary macroadenoma causing acromegaly undergoes endoscopic endonasal resection. Postoperative day 1 labs show serum sodium 142 mmol/L and urine output 3.5 L/day. On day 7, sodium is 128 mmol/L with serum osmolality 265 mOsm/kg and urine osmolality 600 mOsm/kg; he is clinically euvolemic. Morning cortisol is 15 µg/dL. On day 12, sodium falls to 118 mmol/L despite fluid restriction, and he becomes confused; serum osmolality 250 mOsm/kg, urine osmolality 750 mOsm/kg. MRI shows no new findings. Which mechanism best explains this delayed worsening hyponatremia?", "options": ["Persistent syndrome of inappropriate antidiuretic hormone secretion (SIADH) from hypothalamic neuronal injury", "Triphasic water balance disorder with transition from SIADH phase to late-phase permanent diabetes insipidus", "Cerebral salt wasting due to subclinical subarachnoid hemorrhage during surgery", "Reset osmostat due to chronic hyponatremia from preoperative growth hormone excess", "Glucocorticoid deficiency from delayed postoperative hypopituitarism"], "answer": "A", "answer_index": 0, "explanation": "The typical triphasic pattern after pituitary surgery is early DI, then SIADH-related hyponatremia around days 5-10; persistent, severe, euvolemic hyponatremia with high urine osmolality is most consistent with sustained SIADH. Transition to DI (B) would cause hypernatremia and dilute urine. Cerebral salt wasting (C) would show hypovolemia and high urine sodium but is rare here. Reset osmostat (D) would not present with acute confusion at Na 118. Cortisol deficiency (E) is unlikely with normal morning cortisol.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V (Valid). Verdict: Correct best answer. The vignette describes the classic 'second phase' of the triphasic response following pituitary surgery, characterized by SIADH (Syndrome of Inappropriate Antidiuretic Hormone). Key stem clues include the timeline (worsening hyponatremia days 7–12), clinical euvolemia, hypotonicity (Serum Osm 250), and inappropriately concentrated urine (Urine Osm 750). Option A correctly identifies the mechanism: unregulated release of ADH from injured hypothalamic/posterior pituitary neurons. Option B is incorrect because the transition to the third phase (permanent DI) would manifest as polyuria, dilute urine, and hypernatremia, not worsening hyponatremia. Option C (Cerebral Salt Wasting) is excluded by the patient's euvolemic status (CSW causes hypovolemia). Option E is unlikely given the robust morning cortisol (15 µg/dL) on Day 7. Option D (Reset Osmostat) does not explain the progressive, severe drop to 118 mmol/L with confusion. The item is medically accurate and logically sound.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid). Verdict: Correct best answer. The vignette describes the classic 'second phase' of the triphasic response following pituitary surgery, characterized by SIADH (Syndrome of Inappropriate Antidiuretic Hormone). Key stem clues include the timeline (worsening hyponatremia days 7–12), clinical euvolemia, hypotonicity (Serum Osm 250), and inappropriately concentrated urine (Urine Osm 750). Option A correctly identifies the mechanism: unregulated release of ADH from injured hypothalamic/posterior pituitary neurons. Option B is incorrect because the transition to the third phase (permanent DI) would manifest as polyuria, dilute urine, and hypernatremia, not worsening hyponatremia. Option C (Cerebral Salt Wasting) is excluded by the patient's euvolemic status (CSW causes hypovolemia). Option E is unlikely given the robust morning cortisol (15 µg/dL) on Day 7. Option D (Reset Osmostat) does not explain the progressive, severe drop to 118 mmol/L with confusion. The item is medically accurate and logically sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-013", "question": "A 69-year-old man with T2N0M0 glottic squamous cell carcinoma extending to the anterior commissure is planned for definitive radiotherapy. He is a heavy smoker with severe COPD and cannot tolerate prolonged immobilization. The radiation oncologist must choose the optimal fractionation regimen to maximize local control while minimizing acute laryngeal edema and long-term dysphagia. Which regimen best balances these goals?", "options": ["Conventional 2.0 Gy per fraction to 70 Gy over 7 weeks", "Hypofractionated 2.25 Gy per fraction to 63 Gy over 5.6 weeks", "Hyperfractionated 1.2 Gy twice daily to 79.2 Gy total dose", "Concomitant boost regimen with 1.8 Gy daily plus 1.5 Gy second daily fraction in the final 3 weeks", "Stereotactic body radiotherapy (SBRT) 7.5 Gy × 5 fractions to the glottic larynx"], "answer": "B", "answer_index": 1, "explanation": "For early to select T2 glottic cancers, modest hypofractionation (e.g., 2.25 Gy/fraction to ~63 Gy) improves local control with acceptable toxicity and shorter overall treatment time, particularly useful in patients with limited tolerance for prolonged immobilization. Conventional fractionation (A) is effective but less optimal in control and time. Hyperfractionation (C) and concomitant boost (D) increase mucosal toxicity. SBRT (E) for glottic cancer remains investigational with concerns about cartilage necrosis and voice quality.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The clinical scenario describes a patient with T2 glottic squamous cell carcinoma who requires definitive radiotherapy but has comorbidities (COPD, difficulty with immobilization) favoring a shorter treatment course with optimal control. Hypofractionation (Option B: 2.25 Gy/fraction to 63 Gy) is a widely accepted standard of care for T1/T2 glottic cancer. Evidence suggests it offers superior or equivalent local control compared to conventional fractionation (Option A) due to the high alpha/beta ratio of squamous cell carcinoma and shorter overall treatment time, which combats accelerated repopulation. Furthermore, it reduces the total number of treatment visits (28 vs. 35), benefiting a patient with severe COPD. Hyperfractionation (Option C) and concomitant boost (Option D) are valid strategies for advanced head and neck cancer but are logistically difficult (BID treatment) and associated with higher acute toxicity (mucositis/edema), contradicting the stem's goals. SBRT (Option E) is investigational and carries risks of cartilage necrosis. The key (B) is medically accurate and logically supported by the stem's constraints.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The clinical scenario describes a patient with T2 glottic squamous cell carcinoma who requires definitive radiotherapy but has comorbidities (COPD, difficulty with immobilization) favoring a shorter treatment course with optimal control. Hypofractionation (Option B: 2.25 Gy/fraction to 63 Gy) is a widely accepted standard of care for T1/T2 glottic cancer. Evidence suggests it offers superior or equivalent local control compared to conventional fractionation (Option A) due to the high alpha/beta ratio of squamous cell carcinoma and shorter overall treatment time, which combats accelerated repopulation. Furthermore, it reduces the total number of treatment visits (28 vs. 35), benefiting a patient with severe COPD. Hyperfractionation (Option C) and concomitant boost (Option D) are valid strategies for advanced head and neck cancer but are logistically difficult (BID treatment) and associated with higher acute toxicity (mucositis/edema), contradicting the stem's goals. SBRT (Option E) is investigational and carries risks of cartilage necrosis. The key (B) is medically accurate and logically supported by the stem's constraints.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-014", "question": "A 60-year-old man with severe COPD (FEV1 30% predicted) undergoes right pneumonectomy for central squamous cell carcinoma. On postoperative day 3 he develops sudden respiratory distress, hypotension, and jugular venous distention. CXR shows mediastinal shift toward the left (remaining lung side) with hyperinflation and flattened diaphragm. Emergent bronchoscopy reveals no mucus plug. Echocardiogram shows right ventricular dilation and compression of the left atrium. Which is the most likely diagnosis?", "options": ["Postpneumonectomy pulmonary edema of the remaining lung", "Early bronchopleural fistula with tension pneumothorax on the pneumonectomy side", "Acute pulmonary embolism to the left pulmonary artery", "Postpneumonectomy syndrome due to mediastinal shift and bronchial kinking", "Cardiac tamponade from postoperative hemopericardium"], "answer": "D", "answer_index": 3, "explanation": "Postpneumonectomy syndrome is due to excessive mediastinal shift causing kinking/compression of the remaining main bronchus and cardiovascular structures; though classically delayed, it can present early with hyperinflation of the remaining lung and mediastinal shift toward it, leading to RV dilation and LA compression. Pulmonary edema (A) would not explain marked mediastinal shift. Tension pneumothorax on the pneumonectomy side (B) would shift mediastinum away from the remaining lung. Massive PE (C) lacks imaging features of overinflation and shift. Tamponade (E) shows equal chamber pressures but not lung overinflation or shift.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Thoracic Surgery", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a patient with a right pneumonectomy who develops sudden shock (hypotension, JVD) and mediastinal shift toward the remaining left lung. This constellation of findings—obstructive shock with mediastinal shift away from the operative side—is the classic presentation of a tension pneumothorax in the post-pneumonectomy space, typically caused by a bronchopleural fistula (Option B). The keyed answer, Postpneumonectomy Syndrome (D), is characterized by excessive mediastinal shift *into* the empty space (toward the right), which stretches and kinks the airway/vessels. The stem describes the exact opposite direction of shift ('toward the left'). The author's explanation incorrectly asserts that PPS involves a shift toward the remaining lung; physically, a shift toward the remaining lung compresses it rather than causing the 'hyperinflation' described, unless the hyperinflation refers to the patient's baseline severe COPD. Because the stem supports a unique best answer (B) based on the directional vector and hemodynamics, but the key is D, the item is miskeyed.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a patient with a right pneumonectomy who develops sudden shock (hypotension, JVD) and mediastinal shift toward the remaining left lung. This constellation of findings—obstructive shock with mediastinal shift away from the operative side—is the classic presentation of a tension pneumothorax in the post-pneumonectomy space, typically caused by a bronchopleural fistula (Option B). The keyed answer, Postpneumonectomy Syndrome (D), is characterized by excessive mediastinal shift *into* the empty space (toward the right), which stretches and kinks the airway/vessels. The stem describes the exact opposite direction of shift ('toward the left'). The author's explanation incorrectly asserts that PPS involves a shift toward the remaining lung; physically, a shift toward the remaining lung compresses it rather than causing the 'hyperinflation' described, unless the hyperinflation refers to the patient's baseline severe COPD. Because the stem supports a unique best answer (B) based on the directional vector and hemodynamics, but the key is D, the item is miskeyed.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-015", "question": "A 67-year-old woman with lifestyle-limiting claudication and rest pain in the right foot has an occluded right common iliac artery and diffuse calcific disease of the ipsilateral external iliac and common femoral arteries. The left iliac system is patent with a prior kissing stent at the aortic bifurcation. Coronary disease and frailty preclude aortobifemoral bypass. Which revascularization option best optimizes long-term patency and limb salvage?", "options": ["Right axillo-femoral bypass using an 8-mm ringed PTFE graft to the common femoral artery", "Endovascular recanalization and stenting of the occluded right common iliac plus external iliac angioplasty", "Femoral-femoral crossover bypass from left common femoral artery to right profunda femoris artery with endarterectomy of the right common femoral", "Endovascular iliac recanalization combined with drug-coated balloon angioplasty of the common femoral artery", "Ilio-femoral bypass from left common iliac artery to right common femoral artery via a retroperitoneal route"], "answer": "C", "answer_index": 2, "explanation": "Given a hostile aorta and existing left iliac stent, fem-fem crossover with CFA endarterectomy to the profunda provides robust inflow and durable outflow while avoiding major aortic surgery. Axillo-femoral bypass (A) has lower long-term patency. Pure endovascular recanalization (B, D) may be limited by heavy CFA calcification and restenosis risk, and CFA is a poor stent target. Ilio-femoral bypass (E) is more invasive and may be technically challenging given the prior kissing stent and comorbidities.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Vascular Surgery", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The vignette describes a patient with Critical Limb Ischemia, a unilateral right iliac occlusion, and severe common femoral artery (CFA) calcification. The patient is high-risk (frail, coronary disease), precluding aortobifemoral bypass. The key discriminating factors are the patent contralateral (left) iliac system and the calcified right CFA. Option C is the clear best answer: Femoral-femoral crossover bypass is the standard extra-anatomic choice for unilateral iliac disease when aortic surgery is contraindicated, offering superior patency to axillo-femoral bypass (Option A). Crucially, the 'diffuse calcific disease' of the CFA mandates surgical Common Femoral Endarterectomy (CFAE) to ensure durable inflow/outflow; endovascular interventions in the CFA (Options B and D) are generally contraindicated or inferior due to risks of stent fracture and restenosis in this mobile, calcified zone. Option E is unnecessarily invasive and technically hazardous given the prior kissing stents. The item accurately reflects vascular surgery standards.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The vignette describes a patient with Critical Limb Ischemia, a unilateral right iliac occlusion, and severe common femoral artery (CFA) calcification. The patient is high-risk (frail, coronary disease), precluding aortobifemoral bypass. The key discriminating factors are the patent contralateral (left) iliac system and the calcified right CFA. Option C is the clear best answer: Femoral-femoral crossover bypass is the standard extra-anatomic choice for unilateral iliac disease when aortic surgery is contraindicated, offering superior patency to axillo-femoral bypass (Option A). Crucially, the 'diffuse calcific disease' of the CFA mandates surgical Common Femoral Endarterectomy (CFAE) to ensure durable inflow/outflow; endovascular interventions in the CFA (Options B and D) are generally contraindicated or inferior due to risks of stent fracture and restenosis in this mobile, calcified zone. Option E is unnecessarily invasive and technically hazardous given the prior kissing stents. The item accurately reflects vascular surgery standards.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-016", "question": "A 58-year-old man with a 3.8-cm right thyroid nodule and compressive symptoms undergoes total thyroidectomy. Final pathology shows a 3.8-cm encapsulated follicular-patterned lesion with capsular and focal vascular invasion in 2 of 8 intracapsular vessels, RAS-mutant, no extrathyroidal extension, and no lymph node involvement. According to modern risk stratification and evolving nomenclature, which postoperative management is most appropriate?", "options": ["Classify as noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) and no further therapy", "Classify as minimally invasive follicular thyroid carcinoma and recommend routine radioactive iodine ablation", "Classify as encapsulated angioinvasive follicular variant papillary thyroid carcinoma and consider RAI only if postoperative thyroglobulin is detectable", "Classify as low-risk differentiated thyroid carcinoma managed with levothyroxine to keep TSH mildly suppressed and no routine RAI", "Classify as high-risk due to vascular invasion and treat with high-dose RAI and aggressive TSH suppression (<0.1 mIU/L)"], "answer": "D", "answer_index": 3, "explanation": "Encapsulated follicular-patterned tumors with limited vascular invasion (≤4 foci) and no extrathyroidal extension are considered low-risk differentiated thyroid carcinomas; current guidelines favor TSH suppression and no routine RAI, particularly in RAS-mutated lesions without nodal disease. NIFTP (A) requires no invasion; this lesion shows both capsular and vascular invasion. Routine RAI (B, E) is excessive for low-risk tumors. Labeling as high-risk (E) is not justified by limited angioinvasion alone. Option C misclassifies the entity and overemphasizes histologic subtype.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Endocrine", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: Valid (V). Verdict: Correct best answer. The stem describes a 3.8 cm encapsulated follicular-patterned lesion with limited vascular invasion (2 vessels) and no nodal disease. Key clues are the specific count of invaded vessels (<4) and the absence of extrathyroidal extension. \\n\\nMedical reasoning: \\n1.  **Diagnosis**: The presence of invasion (capsular and vascular) rules out NIFTP (Option A). The distinction between Follicular Thyroid Carcinoma (FTC) and Follicular Variant Papillary Thyroid Carcinoma (FVPTC) depends on nuclear features not explicitly detailed, but Option D uses the umbrella term \\\"Differentiated Thyroid Carcinoma\\\" (DTC), which covers both.\\n2.  **Risk Stratification**: While strict 2015 ATA guidelines placed all vascular invasion in 'Intermediate Risk', modern consensus (WHO 2017, NCCN) distinguishes between limited (<4 foci) and extensive (≥4 foci) angioinvasion. Limited angioinvasion has a prognosis similar to minimally invasive (capsular invasion only) disease, often reclassified as low-risk or favorable-intermediate.\\n3.  **Management**: For encapsulated DTC with limited angioinvasion, routine Radioactive Iodine (RAI) is not recommended (de-escalation). Option D correctly identifies the management (no routine RAI) and the prognostic category (low-risk behavior). Option B uses incorrect terminology (minimally invasive = capsular only) and aggressive management. Option E is incorrect as high-risk requires extensive invasion.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: Valid (V). Verdict: Correct best answer. The stem describes a 3.8 cm encapsulated follicular-patterned lesion with limited vascular invasion (2 vessels) and no nodal disease. Key clues are the specific count of invaded vessels (<4) and the absence of extrathyroidal extension. \n\nMedical reasoning: \n1.  **Diagnosis**: The presence of invasion (capsular and vascular) rules out NIFTP (Option A). The distinction between Follicular Thyroid Carcinoma (FTC) and Follicular Variant Papillary Thyroid Carcinoma (FVPTC) depends on nuclear features not explicitly detailed, but Option D uses the umbrella term \"Differentiated Thyroid Carcinoma\" (DTC), which covers both.\n2.  **Risk Stratification**: While strict 2015 ATA guidelines placed all vascular invasion in 'Intermediate Risk', modern consensus (WHO 2017, NCCN) distinguishes between limited (<4 foci) and extensive (≥4 foci) angioinvasion. Limited angioinvasion has a prognosis similar to minimally invasive (capsular invasion only) disease, often reclassified as low-risk or favorable-intermediate.\n3.  **Management**: For encapsulated DTC with limited angioinvasion, routine Radioactive Iodine (RAI) is not recommended (de-escalation). Option D correctly identifies the management (no routine RAI) and the prognostic category (low-risk behavior). Option B uses incorrect terminology (minimally invasive = capsular only) and aggressive management. Option E is incorrect as high-risk requires extensive invasion.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-017", "question": "A 66-year-old man with long-standing diabetes and peripheral neuropathy presents with chronic mesenteric ischemia symptoms and weight loss. CTA shows high-grade stenoses of both the celiac and superior mesenteric arteries (SMA) with a patent inferior mesenteric artery and extensive collateralization. There is a focal 2.5-cm jejunal stricture with mild upstream dilation but no mass. Intraoperatively, the bowel is patchy but viable; the stricture is firm and fibrotic. Biopsy shows transmural fibrosis without active vasculitis. Which strategy best addresses both symptoms and long-term gut viability?", "options": ["Endovascular stenting of SMA only, leaving celiac stenosis untreated", "Open antegrade aorto-SMA bypass plus segmental resection of the jejunal stricture", "Isolated resection of the jejunal stricture without mesenteric revascularization", "Retrograde iliac-to-SMA bypass only, with no bowel resection to avoid short-bowel risk", "Endovascular stenting of both celiac and SMA followed by observation of the stricture"], "answer": "B", "answer_index": 1, "explanation": "Symptomatic chronic mesenteric ischemia with structural fibrotic jejunal stricture requires both durable inflow restoration and removal of the fixed lesion; open aorto-SMA bypass offers superior long-term patency in multivessel disease, and resection treats the fibrotic stricture. SMA-only stenting (A) or dual-vessel stenting (E) may have higher restenosis and do not resolve fixed fibrosis. Resection alone (C) ignores global ischemia. Retrograde iliac-SMA bypass without resection (D) leaves a mechanical obstruction.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette describes a patient with symptomatic chronic mesenteric ischemia (CMI) and a specific complication: a fibrotic jejunal stricture causing upstream dilation. The phrase 'Intraoperatively' implies the patient is currently undergoing surgery, making open surgical options immediately relevant. The clinical priority is twofold: restore pulsatile blood flow to the gut (to treat CMI and ensure anastomotic healing) and remove the mechanical obstruction (the fibrotic stricture). Option B is the only choice that addresses both pathologies: aorto-SMA bypass provides durable revascularization, and segmental resection treats the fixed obstruction. Options A and E (endovascular) and D (bypass only) neglect the fibrotic stricture, which will not resolve with revascularization alone. Option C (resection only) is medically contraindicated because creating an anastomosis in a globally ischemic bowel has a high risk of leak and failure. The item is logically sound, medically accurate, and the key is the only defensible best answer.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette describes a patient with symptomatic chronic mesenteric ischemia (CMI) and a specific complication: a fibrotic jejunal stricture causing upstream dilation. The phrase 'Intraoperatively' implies the patient is currently undergoing surgery, making open surgical options immediately relevant. The clinical priority is twofold: restore pulsatile blood flow to the gut (to treat CMI and ensure anastomotic healing) and remove the mechanical obstruction (the fibrotic stricture). Option B is the only choice that addresses both pathologies: aorto-SMA bypass provides durable revascularization, and segmental resection treats the fixed obstruction. Options A and E (endovascular) and D (bypass only) neglect the fibrotic stricture, which will not resolve with revascularization alone. Option C (resection only) is medically contraindicated because creating an anastomosis in a globally ischemic bowel has a high risk of leak and failure. The item is logically sound, medically accurate, and the key is the only defensible best answer.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-018", "question": "A 52-year-old woman with a history of Roux-en-Y gastric bypass 8 years ago presents with refractory iron-deficiency anemia and vague postprandial epigastric pain. EGD and colonoscopy are negative. Capsule endoscopy shows a circumferential, friable lesion in the excluded stomach. CT enterography confirms a 3.5-cm mass in the excluded gastric remnant without metastatic disease. Which surgical approach is most appropriate for oncologic control and access limitations?", "options": ["Laparoscopic transgastric gastroscopy through the gastric pouch with submucosal dissection of the lesion", "Laparoscopic-assisted resection of the excluded stomach mass via gastrotomy in the remnant and wedge resection", "Conversion of the Roux-en-Y gastric bypass to normal anatomy followed by subtotal gastrectomy", "Open completion gastrectomy including the excluded stomach with Roux-en-Y esophagojejunostomy", "Endoscopic ultrasound-guided radiofrequency ablation of the mass via transluminal puncture from the alimentary limb"], "answer": "D", "answer_index": 3, "explanation": "A 3.5-cm circumferential, friable mass in the excluded stomach is highly suspicious for carcinoma; completion gastrectomy provides oncologic resection with appropriate lymphadenectomy, best achieved via open approach given altered anatomy and access. Laparoscopic wedge resection (B) is inadequate for circumferential malignancy. Converting anatomy first (C) adds complexity without oncologic benefit. Transgastric endoscopic resection (A) and RFA (E) are inappropriate for likely invasive carcinoma in an excluded segment.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The question describes a patient with a Roux-en-Y gastric bypass presenting with a 3.5-cm circumferential, friable mass in the excluded gastric remnant, highly suspicious for locally advanced gastric adenocarcinoma. The standard of care for gastric cancer is formal resection with negative margins and regional lymphadenectomy. Option B (wedge resection) is oncologically inadequate as it fails to retrieve lymph nodes or ensure wide margins. Option A (ESD) and E (RFA) are inappropriate for a large, likely invasive mass. Option C (reversal first) is unnecessary and adds morbidity. Option D is the best answer. Although the tumor is in the remnant, a proper oncologic resection (often requiring D2 lymphadenectomy) typically involves ligating the left gastric artery, which is the primary blood supply to the gastric pouch. Therefore, to achieve oncologic clearance and avoid pouch ischemia, the standard approach is often a completion total gastrectomy (removing both remnant and pouch) with esophagojejunostomy. The 'open' approach is defensible given the anticipated adhesions and complexity ('access limitations'). The item is medically accurate and logically sound.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The question describes a patient with a Roux-en-Y gastric bypass presenting with a 3.5-cm circumferential, friable mass in the excluded gastric remnant, highly suspicious for locally advanced gastric adenocarcinoma. The standard of care for gastric cancer is formal resection with negative margins and regional lymphadenectomy. Option B (wedge resection) is oncologically inadequate as it fails to retrieve lymph nodes or ensure wide margins. Option A (ESD) and E (RFA) are inappropriate for a large, likely invasive mass. Option C (reversal first) is unnecessary and adds morbidity. Option D is the best answer. Although the tumor is in the remnant, a proper oncologic resection (often requiring D2 lymphadenectomy) typically involves ligating the left gastric artery, which is the primary blood supply to the gastric pouch. Therefore, to achieve oncologic clearance and avoid pouch ischemia, the standard approach is often a completion total gastrectomy (removing both remnant and pouch) with esophagojejunostomy. The 'open' approach is defensible given the anticipated adhesions and complexity ('access limitations'). The item is medically accurate and logically sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-019", "question": "A 45-year-old man with newly diagnosed mantle cell lymphoma receives R-CHOP followed by high-dose cytarabine. Six months later, he presents with worsening fatigue. CBC shows Hb 7.5 g/dL, MCV 105 fL, WBC 2,000/µL, platelets 40,000/µL. Bone marrow biopsy shows 18% myeloblasts with multilineage dysplasia and complex cytogenetics including monosomy 7. Flow cytometry is consistent with therapy-related myelodysplastic syndrome evolving toward AML. He has an HCT-CI score of 4 and a matched unrelated donor. Which management approach offers the best chance of long-term survival?", "options": ["Continue R-CHOP for mantle cell lymphoma and start azacitidine for t-MDS", "High-intensity induction chemotherapy with 7+3 followed by allogeneic stem cell transplantation in first remission", "Azacitidine plus venetoclax for cytoreduction, then allogeneic stem cell transplantation when feasible", "Supportive care only with transfusions and growth factors due to high transplant risk", "Immediate reduced-intensity allogeneic transplantation without further cytoreduction"], "answer": "C", "answer_index": 2, "explanation": "Therapy-related MDS/AML with complex karyotype has poor prognosis; hypomethylating agent plus venetoclax can achieve remissions with better tolerability than intensive 7+3 in a comorbid patient, allowing subsequent allogeneic transplant for potential cure. Continuing lymphoma chemo (A) ignores aggressive secondary myeloid disease. High-intensity induction (B) risks excess toxicity given HCT-CI 4. Supportive care alone (D) is palliative. Immediate RIC transplant without cytoreduction (E) in 18% blasts is associated with high relapse and graft failure rates.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Hematology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The patient has therapy-related MDS/AML (t-MN) with high-risk features (complex karyotype, monosomy 7) and significant comorbidities (HCT-CI 4) following recent intensive chemotherapy. The goal is curative allogeneic stem cell transplantation (Allo-SCT). Option A is incorrect as R-CHOP is inappropriate for high-grade myeloid neoplasia. Option D is palliative. Option E (immediate transplant) carries an unacceptably high risk of relapse given the high disease burden (18% blasts). The discrimination lies between B (7+3 induction) and C (HMA+Venetoclax). While 7+3 is the traditional standard for young patients, t-MN with complex cytogenetics is notoriously chemo-refractory to standard cytarabine/anthracycline, and the patient's HCT-CI score of 4 predicts high toxicity. HMA+Venetoclax has emerged as a superior strategy for patients with adverse biology or comorbidities to achieve remission with lower toxicity prior to transplant. Therefore, C is the unique best answer reflecting modern management of high-risk t-MN.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The patient has therapy-related MDS/AML (t-MN) with high-risk features (complex karyotype, monosomy 7) and significant comorbidities (HCT-CI 4) following recent intensive chemotherapy. The goal is curative allogeneic stem cell transplantation (Allo-SCT). Option A is incorrect as R-CHOP is inappropriate for high-grade myeloid neoplasia. Option D is palliative. Option E (immediate transplant) carries an unacceptably high risk of relapse given the high disease burden (18% blasts). The discrimination lies between B (7+3 induction) and C (HMA+Venetoclax). While 7+3 is the traditional standard for young patients, t-MN with complex cytogenetics is notoriously chemo-refractory to standard cytarabine/anthracycline, and the patient's HCT-CI score of 4 predicts high toxicity. HMA+Venetoclax has emerged as a superior strategy for patients with adverse biology or comorbidities to achieve remission with lower toxicity prior to transplant. Therefore, C is the unique best answer reflecting modern management of high-risk t-MN.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-020", "question": "A 32-year-old man with long-standing severe atopic dermatitis refractory to topical steroids and cyclosporine is started on dupilumab (anti-IL-4Rα). After 5 months, his skin disease improves markedly, but he develops new-onset peripheral eosinophilia (AEC 3,000/µL), adult-onset asthma, and transient pulmonary infiltrates on CT. ANCA is negative, and biopsy of a skin nodule shows eosinophil-rich vasculitis of small vessels. Which immunologic mechanism best explains this paradoxical adverse event?", "options": ["Unopposed IL-5-mediated eosinophil proliferation due to blockade of IL-4/IL-13 signaling", "Expansion of Th17 cells with increased IL-17 production driven by IL-4 pathway inhibition", "Emergence of autoreactive B cells secondary to impaired regulatory T-cell differentiation", "Type I interferon upregulation resulting from altered JAK-STAT signaling downstream of IL-4Rα", "Loss of IL-31 signaling leading to compensatory mast cell activation and eosinophilia"], "answer": "A", "answer_index": 0, "explanation": "Dupilumab blocks IL-4/IL-13 signaling, which can shift the Th2 cytokine milieu and lead to relative dominance of IL-5-driven eosinophil proliferation and activation, precipitating eosinophilic vasculitis/EGPA-like syndromes in susceptible patients. Th17 expansion (B), autoreactive B cells via Treg failure (C), interferon upregulation (D), or IL-31/mast cell effects (E) do not directly account for marked eosinophilia and small-vessel eosinophilic vasculitis associated with IL-4Rα blockade.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Immunology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The item describes a classic case of dupilumab-associated unmasking or induction of Eosinophilic Granulomatosis with Polyangiitis (EGPA). The clinical presentation (asthma, eosinophilia, pulmonary infiltrates, vasculitis) is characteristic of EGPA. Dupilumab blocks the IL-4Rα receptor, inhibiting IL-4 and IL-13 signaling, but does not inhibit IL-5. IL-5 is the primary cytokine responsible for eosinophil differentiation, survival, and activation. The mechanism of dupilumab-associated eosinophilia/EGPA is generally understood as the persistence of IL-5 signaling (which drives eosinophilia) in the setting of IL-4/IL-13 blockade, or the inhibition of eosinophil tissue migration (normally driven by IL-4/13-induced chemokines) leading to blood accumulation, though the vasculitis implies tissue pathology driven by active eosinophils. Option A correctly identifies IL-5 as the driver of the eosinophilic pathology in the absence of IL-5 inhibition. The other options (Th17, autoreactive B cells, Type I IFN, IL-31) describe mechanisms unrelated to eosinophilic vasculitis. The item is logically sound and medically accurate in the context of board-level immunology.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item describes a classic case of dupilumab-associated unmasking or induction of Eosinophilic Granulomatosis with Polyangiitis (EGPA). The clinical presentation (asthma, eosinophilia, pulmonary infiltrates, vasculitis) is characteristic of EGPA. Dupilumab blocks the IL-4Rα receptor, inhibiting IL-4 and IL-13 signaling, but does not inhibit IL-5. IL-5 is the primary cytokine responsible for eosinophil differentiation, survival, and activation. The mechanism of dupilumab-associated eosinophilia/EGPA is generally understood as the persistence of IL-5 signaling (which drives eosinophilia) in the setting of IL-4/IL-13 blockade, or the inhibition of eosinophil tissue migration (normally driven by IL-4/13-induced chemokines) leading to blood accumulation, though the vasculitis implies tissue pathology driven by active eosinophils. Option A correctly identifies IL-5 as the driver of the eosinophilic pathology in the absence of IL-5 inhibition. The other options (Th17, autoreactive B cells, Type I IFN, IL-31) describe mechanisms unrelated to eosinophilic vasculitis. The item is logically sound and medically accurate in the context of board-level immunology.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]